These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers. Kelloff GJ; O'Shaughnessy JA; Gordon GB; Hawk ET; Sigman CC Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):593-6. PubMed ID: 12869396 [No Abstract] [Full Text] [Related]
18. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development. Meyskens FL Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2038-41. PubMed ID: 17119025 [No Abstract] [Full Text] [Related]